BigCapital beta

Moscow Exchange · APTK · IFRS

36.6 Pharmacy Chain: revenue, profit and cash flow

In 2025, 36.6 Pharmacy Chain had revenue of ₽106B and a net profit of ₽263M, according to its consolidated IFRS statements. Here: 13 years of annual reports since 2012, each linked to the original document.

Revenue, 2025

₽106B+21.2%

change against 2024

Net profit
₽263M
0.2% of revenue
Earnings per share, 2025
₽0.04
Operating cash flow
₽5.07B
Capital expenditure
₽993M
Free cash flow
₽4.08B
operating cash flow minus capital expenditure
Net debt
₽21.8B
borrowings minus cash; leases not included
Total assets
₽64.1B
Equity
−₽7.3B

Where the money goes

Of every ₽100 of revenue in 2025, 36.6 Pharmacy Chain spent ₽66.9 on the cost of its products and services and ₽32.6 on running the business; ₽0.2 went to income tax, and ₽0.2 was left as net profit.

2025 · rubles · share of revenue
In 2025AmountOf revenue
Revenue₽106B100.0%
Cost of revenue−₽70.7B66.9%
Gross profit₽35B33.1%
Operating expenses−₽34.5B32.6%
Profit before tax₽491M0.5%
Income tax−₽228M0.2%
Net profit₽263M0.2%

Revenue and net profit

Revenue went from ₽14.9B in 2012 to ₽106B in 2025. Net loss in 2012–2013, 2015–2018, 2021.

RevenueNet profit
Rubles, as reported (IFRS); years without a report are left out.

Earnings per share

Basic earnings per share went from −₽9.20 in 2016 to ₽0.04 in 2025. Years before 2016 are left out: the number of shares changed that year, and the reports do not restate the earlier figures to the new count.

Years · rubles per share, basic, adjusted for share splits

Number of shares

The weighted average number of ordinary shares went from 936M in 2015 to 7.51B in 2025.

Years · weighted average ordinary shares, as printed next to earnings per share

Operating cash flow, capex and free cash flow

Free cash flow (operating cash flow minus capital expenditure) was ₽4.08B in 2025, 3.9% of revenue. Negative in 2013–2014, 2016–2018, 2020.

Operating cash flowCapital expenditureFree cash flow
Rubles, as reported (IFRS); years without a report are left out.

What it owns and who paid for it

At the end of 2025, 36.6 Pharmacy Chain had ₽64.1B of assets, ₽1.36B of it in cash, but its liabilities came to ₽71.4B, ₽7.3B more than everything it owns: its shareholders' equity is negative.

End of 2025 · rubles · share of assets · sizes across years on a square-root scale

Net debt

Net debt (borrowings minus cash) was ₽21.8B at the end of 2025.

Net debt
Rubles, as reported (IFRS); years without a report are left out.

36.6 Pharmacy Chain: annual figures

YearRevenueOperating profitNet profitBasic EPSOperating cash flowCapital expenditureFree cash flowNet debtDividends paidTotal assetsEquity
2025₽106B—₽263M₽0.04₽5.07B₽993M₽4.08B₽21.8B—₽64.1B−₽7.3B
2024₽87.2B—₽267M₽0.04₽6.49B₽721M₽5.77B₽21.2B—₽60.8B−₽7.56B
2023*₽67.4B—₽120M₽0.02₽7.05B₽649M₽6.4B₽18.6B—₽53.2B−₽6.83B
2022₽59B—₽223M₽0.03₽6.59B₽694M₽5.9B₽18.1B—₽43.6B−₽6.43B
2021₽44.1B—−₽950M−₽0.10₽3.23B₽699M₽2.53B₽19.9B—₽37.8B−₽6.65B
2020*₽39.3B—₽6.35B₽0.90−₽3.37B₽1.69B−₽5.06B₽39.1B—₽54.4B−₽5.7B
2018₽44.7B—−₽23B−₽9.90−₽9.2B₽645M−₽9.84B₽45.4B—₽32.7B−₽36.8B
2017₽48.3B—−₽13.1B−₽5.60−₽11.1B₽365M−₽11.5B₽31.5B₽0₽39.9B−₽13.8B
2016₽45.9B—−₽9.35B−₽9.20−₽3.48B₽381M−₽3.86B₽19.7B₽0₽44.8B−₽531M
2015*₽31.9B—−₽178M—₽3.81B₽178M₽3.63B₽12.9B₽0₽27.3B₽1.39B
2014₽6.88B₽1.45B₽905M—−₽459M₽75M−₽534M₽10.7B₽0₽16.9B−₽10.1B
2013*₽11.9B−₽7.81B−₽10.4B—−₽4.79B₽38M−₽4.83B₽7.68B₽0₽3.8B−₽10.7B
2012*₽14.9B₽878M−₽971M—₽924M₽124M₽800M₽8.91B₽0₽22.2B₽214M

* Taken from the comparative column of the next year's report: the year's own report was not available to us.

Original reports

Every figure on this page comes from the company's own annual statements. The documents, by year:

How to read these numbers

Source: annual financial statements published by 36.6 Pharmacy Chain (links to the original documents above). Figures read from the documents by BigCapital.

For information only, not investment advice.

Language

EnglishBahasa IndonesiaDeutschEspañolFrançaisItalianoNederlandsPolskiPortuguêsTürkçeРусскийУкраїнська日本語한국어简体中文